| Literature DB >> 31677919 |
Georgi K Kanev1, Chris de Graaf2, Iwan J P de Esch2, Rob Leurs2, Thomas Würdinger3, Bart A Westerman4, Albert J Kooistra5.
Abstract
Kinases are attractive anticancer targets due to their central role in the growth, survival, and therapy resistance of tumor cells. This review explores the two primary kinase classes, the eukaryotic protein kinases (ePKs) and the atypical protein kinases (aPKs), and provides a structure-centered comparison of their sequences, structures, hydrophobic spines, mutation and SNP hotspots, and inhibitor interaction patterns. Despite the limited sequence similarity between these two classes, atypical kinases commonly share the archetypical kinase fold but lack conserved eukaryotic kinase motifs and possess altered hydrophobic spines. Furthermore, atypical kinase inhibitors explore only a limited number of binding modes both inside and outside the orthosteric binding site. The distribution of genetic variations in both classes shows multiple ways they can interfere with kinase inhibitor binding. This multilayered review provides a research framework bridging the eukaryotic and atypical kinase classes.Entities:
Keywords: SNP; catalytic kinase domain structures; eukaryotic and atypical protein kinases; oncogenic mutations; selective kinase inhibitor design; small-molecule kinase inhibitors
Mesh:
Substances:
Year: 2019 PMID: 31677919 DOI: 10.1016/j.tips.2019.09.002
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN: 0165-6147 Impact factor: 14.819